Continuing Medical Education at MCP<>Hahnemann School of Medicine

Category 1 (AMA) CME Credit

MCP<>Hahnemann School of Medicine Allan B. Schwartz, M.D.
Editor-in-Chief
Professor of Medicine
Clinical Service Chief,
Department of Medicine
Director, Continuing Medical Education for the Department of Medicine
MCP Hahnemann University
School of Medicine

Terry Lewis
Director
Office
of Continuing Medical Education
MCP Hahnemann University
School of Medicine


 
MONOGRAPHS

NSAIDS and COX-2 Inhibitors VOL. 9, NUM 3, Summer 1999

After reading this monograph, you will be better able to:

  • recognize the history of NSAID's early uses and different NSAIDS classes;
  • describe the NSAID's mechanisms of action and the prostaglandin pathway;
  • distinguish between the two COX isozymes, their molecular biology, expression sites, regulation and biologic actions;
  • recognize the new COX-2 selective inhibitors, their current uses, side effects and potential therapeutic implications.

Antithrombotic Therapy Mechanisms and Indications, VOL 9, NUM 1, Winter 1999

After reading this monograph, you will be better able to:

  • recognize the newer antithrombotic medications and their indications;
  • classify the specific antithrombotic agents by their mechanisms of action, and recognize their point of action in the coagulation cascade;
  • summarize the current recommendations for antithrombotic therapy in the setting of acute myocardial infarction, unstable angina, percutaneous transluminal cornary angioplasty, mitral stenosis, prosthetic valves, and atrial fibrillation;
  • express the therapeutic target of warfarin using the international normalized ratio; and
  • describe the current advances in the treatment of unstable angina and non-q wave myocardial infarction.

Hypertension Management: Latest Recommendations VOL 8, NUM 3, Fall 1998

After reading this monograph, you will be able to:

  • assess the stages of severity of hypertension;
  • describe the randomized controlled trials (RCT) from which recommendations for the treatment of hypertension were made;
  • recognize the "compelling indications for which specific pharmaceutical agents are recommended as first choice agents rather then beta-blockers and diuretics;
  • determine "special populations" of hypertensive patients for whom specific therapies may be recommended; and
  • utilize combinations of antihypertensive therapies.

The Outpatient Management of HIV VOL 8, NUM 2, Summer 1998

After reading this monograph, you will be able to:

  • describe the frequency and utility of viral load testing;
  • describe the goals of antiretroviral therapy;
  • recognize indications for HIV therapy based on emerging knowledge of HIV pathogenesis and resistance;
  • recognize initial antiretroviral treatment options for people with HIV;
  • manage prophylaxis for opportunistic infections in HIV infection.

Helicobacter Pylori: the Treatable Cause of Ulcer Disease and Gastric Cancers VOL 8, NUM 1, Winter 1998

After reading this monograph, you will be better able to:

  • dentify some of the basic epidemiologic facts about H. pylori infection, including suspected methods of transmission andrisk factors for infection;
  • describe basic pathophysiologic mechanisms behind the clinical manifestations of H. pylori infection;
  • identify which patients are most appropriate for testing for H. pylori; and select at least 6 drug regimens for eradication of H. pylori.
Pathogenesis and Management of Rhabdomyolysis VOL 7, NUM 2, June 1997

After reading this monograph, you will be better able to:

  • describe the pathophysiologic mechanism ofrhabdomyolysis;
  • distinguish the numerous etiologies of rhabdomyolysis;
  • recognize the presenting clinical laboratory features of rhabdomyolysis; and
  • select prophylactic therapy to avoid complications. 
Nuclear Cardiac Imaging VOL 7, NUM 1, March 1997

After reading this monograph, you will be better able to:

  • recognize applications of nuclear cardiac imaging;
  • assess risk factors in patients with coronary artery disease;
  • describe features of left ventricular dysfunction reversibility or irreversibility
  • differentiate the value of the various radionuclide angiographic methods.
Stress Echocardiography in Clinical Practice VOL 6, NO 2, Winter 1996

Over the last several years, technologic advances in stress echocardiography have made this tool highly accurate in detecting coronary artery disease, rivaling its nuclear counterparts. This monograph reviews the value and limitations of stress echocardiography in clinical practice.

 

Asthma: Progress in the Immunophysiology and Epidemiology of Asthma VOL 6, NO 1, Fall 1995

The prevalence of asthma is rising, and since 1978, asthma mortality in the United States has increased dramatically. To improve outcomes for asthma care, consensus guidelines have encouraged an approach to management that places greater emphasis upon pharmacotherapeutic agents that can affect airway inflammation, and have stressed the importance of environmental control, objective measurements of lung function, and fostering patient education and self-management skills.

 

Cardiac Rupture Complicating Acute Myocardial Infarction VOL 5, NO 2, Spring 1995

Cardiac rupture is a common and potentially fatal complication of acute myocardial infarction. Early recognition of clinical, electrocardiographic, and echocardiographic findings can thus be life-saving due to improved care in the early post-myocardial infarction period. This report reviews various forms of myocardial muscle rupture, including that of ventricular septum, papillary muscle, and cardiac free wall.

 

Ocular Manifestations of Rheumatic Disease VOL 5, NO 1, Fall/Winter 1994

Ocular involvement is a common manifestation of many rheumatologic diseases. Physicians must be familiar with not only the systemic but also the ocular manifestations of these diseases to best manage patients and to decrease ocular morbidity and vision loss. This monograph includes several rheumatologic disorders associated with ocular manifestations: rheumatoid arthritis, juvenile rheumatoid arthritis, Sjörgren's syndrome, ankylosing spondylitis, and giant cell arteritis.

 

Pathogenesis and Diagnosis of Aortic Dissection VOL 4, NO 2, Fall/Winter 1993

Aortic dissection is a catastrophic disease if not recognized early and treated promptly. The diagnosis of aortic dissection is easily missed due to its variable clinical presentation mimicking involvement of various organ systems. The mortality rate of untreated aortic dissection is over 1% per hour. As the population over 60 years of age continues to grow, more patients potentially will be at risk for this disease.

 


 
MONOGRAPH INFORMATION

The Medical Monograph Series was planned and produced in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME), as they pertain to enduring materials and commercial support.

Medical Monograph Series (M.M.S.) is a quarterly publication of the Office of Continuing Medical Education, MCP Hahnemann University.

Subscriptions to a printed version are available to individuals for $20.00 annually and to libraries for $30.00 annually.   Inquiries should be addressed to:

M.M.S., Continuing Medical Education
MCP Hahnemann University
Broad and Vine, Mail Stop 623
Philadelphia, Pennsylvania 19102-1192.
Telephone: 215-762-8263.

ACCREDITATION

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians, MCP Hahnemann University designates this continuing medical education activity for 1.5 credit hours in Category I of the Physician's Recognition Award of the American Medical Association. 

FULL DISCLOSURE STATEMENT

All faculty participating in continuing medical education programs sponsored by MCP Hahnemann University are expected to disclose to the audience any real or apparent conflict(s) of interest related to the content of their presentation.


Office of Continuing Medical Education
e-mail: cme@mcphu.edu

©1998 MCP Hahnemann University


This site is administered by Ed Brown II.   Please send messages to brownii@mcphu.edu.

TeleEducation Center (TEC)
Office of Education